Dr. Kikelomo Belizaire Joins Pega as the Company's First Chief Medical Officer

Dr. Kikelomo Belizaire Joins Pega as the Company's First Chief Medical Officer

The low-code platform provider that builds agility into the world's leading organizations, today announced the appointment of Dr. Kikelomo (Dayo) Belizaire as its first chief medical officer. With a strong clinical background and a passion for improving care outcomes, Dr. Belizaire will bring a clinical lens to Pega's strategy for serving its healthcare clients. Dr. Belizaire will leverage her experience as a practicing physician working closely with both payers and providers to help accelerate and inform the development of Pega's healthcare solutions, ensuring they are clinically relevant and help drive better collaboration between all stakeholders. A Board-certified internal medicine physician with a Master of Public Health, Dr. Belizaire's practitioner background will provide a unique perspective to help Pega clients identify opportunities to leverage Pega's low code, AI-powered decisioning and workflow automation capabilities and understand the value it can provide across their organizations. "Digital transformation is crucial in healthcare, and Dr. Belizaire is uniquely qualified to recognize the needs of our clients and ensure Pega solutions meet those needs," said Kelli Bravo, vice president, healthcare and life sciences, Pega. Dr. Belizaire understands the realities of being a healthcare practitioner and will help Pega address our clients' specific pain points and their need to deliver whole-person care."




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 22, 2024 at 12:50pm